CorMatrix® References for CanGaroo®

CorMatrix® References for Vascular Repair

CorMatrix® References for Pericardial Repair & Reconstruction

CorMatrix® References for Tyke®

CorMatrix® References for Cardiac Tissue Repair

CorMatrix® References for CanGaroo®

Use of an Antibacterial Envelope is Associated with Reduced Cardiac Implantable Electronic Device Infections in High-Risk Patients
Matthew J. Kolek, M.D.,a William F. Dresen, M.D.,a Quinn S. Wells, M.D.,a and Christopher R. Ellis, M.D.,b
aDivision of Cardiovascular Medicine, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN;
bCardiovascular Medicine Division, Department of Internal Medicine, Cardiac Electrophysiology Section, Vanderbilt Heart and Vascular Institute, Nashville, TN

Surgical Treatment of Pacemaker and Defibrillator Lead Endocarditis The Impact of Electrode Lead Extraction on Outcome
Ana del Rio, MD,a Ignasi Anguera, MD,b Jose M. Miro, MD, PhD,a Lluis Mont, MD, PhD,aa Manel Azqueta, MD,a Carlos A. Mestres, MD,a and the Hospital Clinic Endocarditis Study Group
aHospital Clinic, Institut d’Investigacions Biome`diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
bHospital de Sabadell, Barcelona, Spain
cDuke University Medical Center, Durham, NC

Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects
Matthew J. Kolek, M.D., M.S.C.I.,a Neel J. Patel, M.D.,a Walter K. Clair, M.D., M.P.H.,a S. Patrick Whalen, M.D.,b Jeffery N. Rottman, M.D.,b Arvindh Kanagasundram, M.D.,a Sharon T. Shen, M.D.,a Pablo J. Saavedra, M.D.,a Juan C. Estrada, M.D.,a Robert L. Abraham, M.D.,a and Christopher R. Ellis, M.D.,a
aDepartment of Medicine, Cardiology Division, Vanderbilt University, Nashville, TN
bDepartment of Medicine, Cardiology Division, Wake Forest University, Winston-Salem, NC

Infections Associated with Cardiac Implantable Electronic Devices Are Misunderstood
Bruce L. Wilkoff, MD
Department of Cardiovascular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

Update on Cardiovascular Implantable Electronic Device Infections and Their Management: A Scientific Statement From the American Heart Association
Endorsed by the Heart Rhythm Society
Larry M. Baddour, MD, FAHA, Chair, Andrew E. Epstein, MD, FAHA, FHRS, Christopher C. Erickson, MD, FAHA, Bradley P. Knight, MD, FHRS, Matthew E. Levison, MD, Peter B. Lockhart, DDS, Frederick A. Masoudi, MD, MSPH, Eric J. Okum, MD, Walter R. Wilson, MD, Lee B. Beerman, MD, Ann F. Bolger, MD, FAHA, N.A. Mark Estes III, MD, FAHA, FHRS, Michael Gewitz, MD, FAHA, Jane W. Newburger, MD, MPH, FAHA, Eleanor B. Schron, PhD, RN, FAHA, Kathryn A. Taubert, PhD, FAHA
On behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; and the Interdisciplinary Council on Quality of Care and Outcomes Research

CorMatrix® References for Vascular Repair

An Experimental Model of Small Intestinal Submucosa As a Growing Vascular Graft
Monica C. Robotin-Johnson, FRACS,1 Paul E. Swanson, MD, David C. Johnson, FRACS, Richard B. Schuessler, PhD, and James L. Cox, MD
1Washington University School of Medicine, St Louis, and Georgetown University School of Medicine, Washington, DC

Comparison of small-intestinal submucosa and expanded polytetrafluoroethylene as a vascular conduit in the presence of gram-positive contamination
Daniel H. Shell, IV, MD, Martin A. Croce, MD, Catherine Cagiannos, MD, T. Wright Jernigan, MD, Norma Edwards, MD, and Timothy C. Fabian, MD
Department of Surgery, University of Tennessee Health Science Center, Memphis, TN

Small intestinal submucosa as a vascular graft: A Review
Garry C. Lantz, DVM,1 Stephen F. Badylak, DVM, PhD, MD,2 Michael C. Hiles, MS,2 Arthur C. Coffey, MS, MD,2 Leslie A. Geddes, ME, PhD,2 Klod Koktni, PhD,3 George E. Sandusky, DVM, PhD,4 and Robert J. Morff, PhD,4
1Department of Veterinary Clinical Sciences, Purdue University, West Lafayette, IN
2Hillenbrand Biomedical Engineering Center Purdue University, West Lafayette, IN
3Scholl of Mechanical Engineering Purdue University, West Lafayette, IN
4Eli Lilly and Co. Indianapolis, IN

Utilization of a tubularized cormatrix extracellular matrix for repair of an arteriovenous fistula aneurysm
Joseph J. DuBose and Ali Azizzadeh
Department of Cardiothoracic and Vascular Surgery, Memorial Hermann Heart and Vascular Institute, University of Texas Medical School, Houston, TX

CorMatrix® References for Pericardial Repair & Reconstruction

A review of the current status of pericardial closure following cardiac surgery
W Douglas Boyd1, John V Tyberg2,3 and James L Cox4
1University of California Davis Medical Center, Davis, CA, USA
2University of Calgary, Faculty of Medicine, Calgary, AB, Canada
3Libin Cardiovascular Institute of Alberta, Calgary, AB, Canada
4Division of Cardiothoracic Surgery, Washington University School of Medicine, St Louis, MO, USA

Histology of CorMatrix Bioscaffold 5 Years After Pericardial Closure
Meghan Stelly, and Terry C. Stelly, MD
Clemson University, Clemson, SC , and Department of Cardiothoracic Surgery, Providence Hospital, Mobile, AL

Identifying patients at particular risk of injury during repeat sternotomy: Analysis of 2555 cardiac reoperations
Chan B. Park, MD,a,b Rakesh M. Suri, MD,a Harold M. Burkhart, MD,a Kevin L. Greason, MD,a Joseph A. Dearani, MD,a Hartzell V. Schaff, MD,a and Thoralf M. Sundt III, MDa
aDivision of Cardiovascular Surgery, Mayo Clinic, Rochester, MN
bDepartment of Thoracic and Cardiovascular Surgery, St. Pauls’s Hospital, The Catholic University of Korea, Seoul, Korea

Should the pericardium be closed in patients undergoing cardiac surgery?
Mohamed N. Bittar, James B. Barnard, Noman Khasati, and Steven Richardson
Department of Cardiothoracic Surgery, Wythenshawe Hospital, Southmoor Road, Manchester M23 9LT, UK

Should the Pericardium Be Closed Routinely After Heart Operations?
Vivek Rao, MD, PhD, Masashi Komeda, MD, PhD, Richard D. Weisel, MD, Gideon Cohen, MD, Michael A. Borger, MD, and Tirone E. David, MD
Division of Cardiovascular Surgery and Centre for Cardiovascular Research, The Toronto Hospital and the University of Toronto, Toronto, Ontario, Canada

CorMatrix® References for Tyke®

Preliminary Experience With Cardiac Reconstruction Using Decellularized Porcine Extracellular Matrix Scaffold: Human Applications in Congenital Heart Disease
Frank G. Scholl, MD,1 Mark M. Boucek, MD, Kak-Chen Chan, MD, MBBS,  Lilliam Valdes-Cruz, MD, and Richard Perryman, MD
1The Cardiac Center, Joe DiMaggio Children’s Hospital, Hollywood, FL, USA

Intestinal Submucosal Patch Reconstruction of Pulmonary Artery in a Newborn Using a Porcine Small
Fariba Chalajour,1 Laura A. Barboza, Lorenzo Boni, Radhika Snyder, Frank L. Hanley, V. Mohan Reddy and R. Kirk Riemer
1Pediatric Cardiac Surgery Division, Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California

Physiological Growth, Remodeling Potential, and Preserved Function of a Novel Bioprosthetic Tricuspid Valve Tubular Bioprosthesis Made of Small Intestinal Submucosa-Derived Extracellular Matrix
Farhan Zafar, MD,a Robert B. Hinton, MD,b Ryan A. Moore, MD,b R. Scott Baker, BS,a Roosevelt Bryant III, MD,a Daria A. Narmoneva, PHD,c Michael D. Taylor, MD, PHD,b David L. Morales, MDa
aDivision of Pediatric Cardiothoracic Surgery, The Heart Institute, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio;
bDivision of Cardiology, The Heart Institute, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio;
cDepartment of Biomedical Engineering, University of Cincinnati, Cincinnati, Ohio

Atrial Rhabdomyoma Resection With Extracellular Matrix Reconstruction of the Right Atrial Free Wall in an Infant
Loretta Erhunmwunsee, MD1, Ryan P. Flanagan, MD, FAAP2, Robert D. B. Jaquiss, MD3, and Andrew J. Lodge, MD3
1Division of Thoracic Surgery, Department of Surgery, City of Hope, Duarte, CA, USA
2Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA
3Division of Pediatric Cardiology, Department of Pediatrics, Womack Army Medical Center, Fort Bragg, NC, USA

CorMatrix® References for Cardiac Tissue Repair

Reconstruction of pulmonary artery with porcine small intestinal submucosa in a lamb surgical model: Viability and growth potential
Lorenzo Boni, MD,a Fariba Chalajour, MD,a Takashi Sasaki, MD,a Radhika Lal Snyder, BA,a Walter D. Boyd, MD,b R. Kirk Riemer, PhD,a and V. Mohan Reddy, MDa
aDivision of Pediatric Cardiac Surgery, Department of Cardiothoracic Surgery, Stanford University, Stanford, CA
b Department of CardiothoracicSurgery, UC Davis Medical Center, Sacramento, CA

Extracellular matrix for reconstruction of cardiac structures after tumour resections
Simon H. Sündermannaa, Oliver Müggler,a Etem Caliskan,a Diana Reser,a Robert Manka,b,c Tomas Holubeca, Martin Czerny,a and Volkmar Falka
aDivision of Cardiovascular Surgery, University Hospital Zurich, Zurich, Switzerland
bInstitute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland
cDepartment of Cardiology, University Hospital Zurich, Zurich, Switzerland

Clinical experience with CorMatrix extracellular matrix in the surgical treatment of mitral valve disease
Marc W. Gerdisch, MD, FACS, FACC, Richard J. Shea, MD, and Michael D. Barron, MD
Cardiac Surgery Associates, Franciscan St Francis Heart Center, Indianapolis, IN

Initial Experience With Intraventricular Repair Using CorMatrix Extracellular Matrix
Bobby Yanagawa, MD, PhD, Vivek Rao, MD, PhD, Terrence M. Yau, MD, and Robert J. Cusimano, MD
Division of Cardiovascular Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, ON